Hyperglycemia Induction in HepG2 Cell Line by Mohamadpour 1, Zinat et al.
                                   I J H S  
International Journal of Health Studies 2016;2(1)       |      28 
IJHS 2016;2(1):28-29 
http://ijhs.shmu.ac.ir 
 
International Journal of Health Studies 
doi: 10.22100/ijhs.v2i0.94 
Original Article 
Hyperglycemia Induction in HepG2 Cell Line 
Zinat Mohamadpour1, Loghman Sharifi1, Marjan Norouzzadeh1, Yas Kalikias1, Maryam Mahmoudi1* 
1 Dept. of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran. 
Received: 28 February 2016 
Accepted: 14 March 2016 
Abstract 
Background: Hyperglycemia is one of the important featurs of 
diabetes. In cell culture studies different methods are used to mimic the 
hyperglycemia condition. In this study we investigate response of 
human liver cancer cell line (HepG2) to high insulin, high glucose,and 
high insulin/ high glucose medium exposure. 
Methods: HepG2 cells were settled in DMEM+0.1% FBS or DMEM 
free-serum medium with high concentrations of d-glucose (30 mm) 
and/or insulin (1μM) for 24h after an overnight starving in serum- free 
medium. The level of hyperglycemia was estimated in the supernatants 
via GOD-POD method. 
Results: Serum-free madium with high insulin/ high glucose 
consentration made the higher level of hypreglycemia in HepG2 cells. 
Conclusions: Our study interduced high insulin/ high glucose 
treatment as the best way to induction hyperglycemia. 
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Introduction 
Diabetes is one of the most common metabolic diseases in 
the world and has caused deaths and disabilities in many 
countries.1Recent studies in America have shown that the 
prevalence of diabetes has increased from 144% in 1980 to 
151% in 2009. Type 2 diabetes mellitus (T2DM) includes more 
than 90% of all diabetes cases.2 T2DM often occurs at an old 
age because of obesity, physical inactivity, unhealthy diet, and 
genetic predisposition. In T2DM, the blood sugar level in the 
body is increased, leading to insulin resistance and other 
complications.3,4 
Hyperglycemia, define as an elevated blood glucose level, 
is one of the important complications of T2DM. It occurs due 
to a malfunction or secretion disorder of insulin. 
Hyperglycemia causes further damage to the beta cells of the 
pancreas, followed by more insulin resistance. Thus, a vicious 
cycle called glucose toxicity occurs in the body.5 
In cell culture studies, hyperglycemia circumstances are 
usually induced to mimic diabetic conditions. In this study we 
have examined the different ways of hyperglycemia induction 
in HepG2 cells to find the best method. 
Materials and Methods 
HepG2 cell lines were purchased from the Iran national cell 
bank, Pasteur Institute. Dulbecco’s modified Eagle’s medium 
F12 (DMEM-F12) was purchased from Gibco-UK. Fetal 
bovine serum (FBS), penicillin, and streptomycin were 
obtained from Sigma-USA. Glucose-Std kits were obtained 
from Pars azmoun -IRI. 
HepG2 cells were cultured in DMEM-F12 supplemented 
with 10% FBS, 100 U/ml penicillin, and 100 mg/ml 
streptomycin in a 37°C humid atmosphere with 5% CO2. The 
cells were seeded onto six-well plates at 1.2 × 106 cells per 
well to reach 80% confluence. To induce insulin resistance, 
HepG2 cells were exposed to a high concentration of D-
glucose (30 mM) and/or high insulin (1 μM) in DMEM + 0.1% 
FBS or serum-free medium for 24 h after an overnight serum-
starving condition. Afterwards, the supernatant was collected 
and the Glucose-Std kit, which uses the glucose oxidase-
peroxidase (GOD-POD) method, was used to estimate the level 
of hyperglycemia. 
Results 
HepG2 cells were treated according to Table 1 for 24 h 
after an overnight starving in serum-free medium. In this 
experiment, treatment with D-glucose (30 mM) and insulin (1 
μM) in serum-free medium increased the level of 
hyperglycemia (Table 1). 
Table1: The glucose level of supernatant in different culture conditions. 
The glucose level of supernatants (mM) 
Treatment  
DMEM+0.1%  FBS ** DMEM * free-serum 
64 72 Insulin 
673 688 Glucose 
688 702 Insulin+ Glucose 
*DMEM:  Dulbecco’s modified Eagle’s  
** FBS:  Fetal bovine serum 
Discussion  
Hyperglycemia or high blood sugar is a condition in which 
an excessive amount of glucose circulates in the blood plasma. 
This is generally a blood sugar level higher than 11.1 mM (200 
mg/dl). A subject with a consistent range above 7 mM (126 
mg/dl) is generally considered to have diabetes, which can 
cause organ damages due to glucose toxicity.6,7 
Many mechanisms have been proposed for glucose toxicity 
as follows:  
• In adipose tissue and skeletal muscle following 
increasing glucosamine levels, intracellular adenosine 
triphosphate (ATP) is depleted and the glucose transporter type 
4 (GLUT4) membrane transport of GLUT4 is suppressed.8 
• In the liver, the regulatory mechanism of glucose 
transporter type 2 (GLUT2) membrane transportation is 
disturbed. Therefore, glucose cannot be a limiting factor for 
glucose metabolism.9 
• The elevated glucose levels lead to an increase in 
serine phosphorylation and a decrease in tyrosine 
phosphorylation of the insulin receptor through 
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phosphatidylinositide 3-kinases/protein kinase B (PI 3-k/ AKT) 
pathway.10 
• Glucose toxicity causes oxidative stress leading to 
active inflammatory pathways, which are followed by 
exacerbation of diabetic symptoms.11 
In T2DM, three of the following phases may occur:1- 
hyperglycemia, followed by 2-hyperinsulinemia, and then 3- 
hyperglycemia, which may overlap with hyperinsulinemia for 
some time. It has been shown that high insulin, high glucose, and 
high glucose/high insulin conditions can damage tissues.12-14 
In this study, we examined the different methods to induce 
a hyperglycemic condition in order to mimic a diabetic 
condition. According to our results, a higher glucose level is 
caused by the treatment of HepG2 cells with high amounts of 
insulin and glucose simultaneously in DMEM medium without 
FBS. Previous studies have suggested the same method to 
induce hyperglycemia in HepG2 cells.10,15,16 However, most of 
the studies conducted induced hypoglycemia using a high 
glucose medium only. Some examples include the following 
conditions: exposing neonatal primary cultured cardiomyocytes 
to 25 mM glucose for different time period in which the 
maximum affect was observed from 24 h to 48 h of high 
glucose stimulation;17 incubation of cardiomyocytes cells with 
33 mM glucose for 36 h;18 treatment of mouse primary 
peritoneal macrophage with 25 mM glucose for 18 h;19 and 
high glucose/high insulin exposure decreases not only insulin-
stimulated GLUT4 translocation in skeletal muscle but also 
insulin receptor and AKT phosphorylation.20 It appears that a 
high glucose/high insulin condition mimics the usual diabetic 
circumstances in which the body increases insulin uptake to 
raise glucose levels. 
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